Morphometric Evaluation of Ultrastructural Changes in Type II Alveolar Cells of Rat Lung Produced by BromhexineGil J. · Thurnheer U.
Anatomisches Institut der Universität Bern (Direktor: Prof. Dr. E. R. Weibel)
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
The influence exerted by the secretolyticum Bisolvon® on rat lungs was examined. The lungs were fixed for electron microscopy by vascular perfusion of the fixatives in order to preserve the extracellular lining layer of alveoli (surfactant). The appearance of this lining layer was identical in Bisolvon-treated animals as compared with controls. But in Bisolvon-animals peculiar, unusually large forms of lamellated bodies of alveolar cells type II could be observed. A morphometric examination of this material demonstrated that the volume of lamellated bodies within alveolar cells type II, but especially the volume of alveolar epithelial cells type II, as compared with the total volume of lung tissue were clearly increased. The conclusion is drawn that these cells, supposed to represent the major source of alveolar surfactant, proliferate or differentiate under the influence of Bisolvon. The possible significance of this finding for the function of pulmonary surfactant is discussed. Additonally, concentric lamellar bodies, which appear to be proliferations of smooth endoplasmic reticulum, were found in alveolar cells type I.
© 1971 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.